help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zenke, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zenke, M.
Molecular Endocrinology 12 (9): 1269-1279
Copyright © 1998 by The Endocrine Society

Retinoid X Receptor and c-erbA/Thyroid Hormone Receptor Regulate Erythroid Cell Growth and Differentiation

Petr Bartunk and Martin Zenke

Max-Delbrück-Center for Molecular Medicine D-13122 Berlin, Germany

Nuclear receptors are important regulators of erythroid cell development. Here we investigated the impact of retinoid X receptor (RXR), retinoic acid receptor (RAR), and of the c-erbA/thyroid hormone (T3) receptor (c-erbA/TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor-dependent erythroid progenitors. RXR, RAR, and c-erbA/TR-specific ligands were found to induce erythroid-specific gene expression and to accelerate erythroid differentiation in culture, with T3 being most effective. Furthermore, while ligand-activated c-erbA/TR accelerated differentiation, unliganded c-erbA/TR effectively blocked differentiation and supported sustained progenitor growth in culture. Thus, c-erbA/TR appears to act as a binary switch affecting erythroid cell fate: unliganded c-erbA/TR supports growth while ligand-activated c-erbA/TR induces differentiation. Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF-1 and AF-2, or AF-2 only, or the entire DNA-binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR-specific effects. It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells. In marked contrast, expression of the dominant interfering {Delta}DNA-binding domain RXR, containing a deletion of the entire DNA-binding domain, was incompatible with erythroid cell growth in vitro, suggesting a pivotal role of RXR for erythroid cell development.




This article has been cited by other articles:


Home page
BloodHome page
K.-R. Koh, M. Janz, M. Y. Mapara, B. Lemke, D. Stirling, B. Dorken, M. Zenke, and S. Lentzsch
Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis
Blood, May 15, 2005; 105(10): 3833 - 3840.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Angelin-Duclos, C. Domenget, A. Kolbus, H. Beug, P. Jurdic, and J. Samarut
Thyroid hormone T3 acting through the thyroid hormone {alpha} receptor is necessary for implementation of erythropoiesis in the neonatal spleen environment in the mouse
Development, March 1, 2005; 132(5): 925 - 934.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Kamiya, M. Puzianowska-Kuznicka, P. McPhie, J. Nauman, S.-y. Cheng, and A. Nauman
Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma
Carcinogenesis, January 1, 2002; 23(1): 25 - 33.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Karafiat, M. Dvorakova, P. Pajer, J. Kralova, Z. Horejsi, V. Cermak, P. Bartunek, M. Zenke, and M. Dvorak
The leucine zipper region of Myb oncoprotein regulates the commitment of hematopoietic progenitors
Blood, December 15, 2001; 98(13): 3668 - 3676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Ingley, D. Chappell, S. Y. K. Poon, M. K. Sarna, J. G. Beaumont, J. H. Williams, J. P. Stillitano, S. Tsai, P. J. Leedman, P. A. Tilbrook, et al.
Thyroid Hormone Receptor-interacting Protein 1 Modulates Cytokine and Nuclear Hormone Signaling in Erythroid Cells
J. Biol. Chem., November 9, 2001; 276(46): 43428 - 43434.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
N. P. Koritschoner, J. Madruga, S. Knespel, G. Blendinger, B. Anzinger, A. Otto, M. Zenke, and P. Bartunek
The Nuclear Orphan Receptor TR4 Promotes Proliferation of Myeloid Progenitor Cells
Cell Growth Differ., November 1, 2001; 12(11): 563 - 572.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Zhu, C. M. Heyworth, A. Glasow, Q.-H. Huang, K. Petrie, M. Lanotte, G. Benoit, R. Gallagher, S. Waxman, T. Enver, et al.
Lineage restriction of the RAR{alpha} gene expression in myeloid differentiation
Blood, October 15, 2001; 98(8): 2563 - 2567.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Panzenbock, P. Bartunek, M. Y. Mapara, and M. Zenke
Growth and Differentiation of Human Stem Cell Factor/Erythropoietin-Dependent Erythroid Progenitor Cells In Vitro
Blood, November 15, 1998; 92(10): 3658 - 3668.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society